Your body needs time to adjust to a new level of GLP-1 receptor activation
A GLP-1 receptor agonist is a medication that mimics a natural hormone in your body that regulates appetite and blood sugar
In published clinical research it is studied for weight management, body weight, appetite, and how it may regulate blood sugar levels, in models relevant to type 2 diabetes and obesity
Semaglutide aids in weight loss only if calorie intake is reduced
There were no differences in older patients with or without comorbidities in either the LixiLan-O or LixiLan-L trials, except for slightly greater weight loss in patients with versus without comorbidities in the LixiLan-O trial (data on file)
Here are some important points to keep in mind: Risk of Low Blood Sugar When Ozempic is combined with medications that increase insulin, like sulfonylureas or insulin itself, there is a higher chance of hypoglycemia